Published On: Wed, Oct 19th, 2016

Analyst Review: Landec Corporation (NASDAQ:LNDC)


A number of investment brokers have recently updated their price targets on shares of Landec Corporation (NASDAQ:LNDC).

Most recent broker ratings

07/08/2016 – Wedbush began new coverage on Landec Corporation giving the company a “neutral” rating. They now have a USD 12 price target on the stock.

06/07/2016 – Maxim Group began new coverage on Landec Corporation giving the company a “buy” rating. They now have a USD 16 price target on the stock.

01/25/2016 – Landec Corporation was upgraded to “buy” by analysts at Sidoti.

12/15/2015 – Landec Corporation had its “buy” rating reiterated by analysts at Roth Capital.

12/08/2015 – Landec Corporation was downgraded to “hold” by analysts at Feltl & Co.. They now have a USD 11.6 price target on the stock.

11/18/2015 – Wunderlich began new coverage on Landec Corporation giving the company a “buy” rating. They now have a USD 18 price target on the stock.

07/30/2015 – Landec Corporation had its “outperform” rating reiterated by analysts at Imperial Capital. They now have a USD 19 price target on the stock.

05/03/2015 – Landec Corporation was downgraded to “sell” by analysts at Zacks.

04/14/2014 – Landec Corporation had its “outperform” rating reiterated by analysts at Northland Securities. They now have a USD 14 price target on the stock.

03/10/2014 – Lake Street began new coverage on Landec Corporation giving the company a “buy” rating.

The share price of Landec Corporation (NASDAQ:LNDC) was down -1.10% during the last day of trading, with a day high of 13.65. 58256 shares were traded during the last session.

The stock’s 50 day moving average is 13.06 and its 200 day moving average is 11.74. The stock’s market capitalization is 367.75M. Landec Corporation has a 52-week low of 9.48 and a 52-week high of 13.75.

Landec Corporation designs, develops, manufactures and sells a range of health and wellness products for food and biomaterials markets. The Company licenses technology applications to partners. The Company operates through three segments: Packaged Fresh Vegetables, Food Export and Biomaterials. The Packaged Fresh Vegetables segment markets and packs specialty packaged whole and fresh-cut fruit and vegetables, the majority of which incorporate the BreatheWay specialty packaging for the retail grocery, club store and food services industry. The Food Export segment is engaged in the purchase and sale of whole commodity fruit and vegetable products primarily to Asia. The Biomaterials segment sells products utilizing hyaluronan, a polysaccharide that is distributed in the extracellular matrix of connective tissues in both animals and humans, and non-hyaluronan (HA) products for medical use primarily in the ophthalmic, orthopedic and other markets.